TipRanks
CSL (AU:CSL)
ASX:CSL
Australian Market
CSL
CSL
RESEARCH TOOLSreports
Want to see AU:CSL full AI Analyst Report?

CSL (CSL) Share Forecast & Price Target

1,001 Followers
See the Price Targets and Ratings of:

CSL Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
6 Buy
5 Hold
0 Sell
Based on 11 analysts giving stock ratings to
CSL
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CSL Stock 12 Month Forecast

Average Price Target

AU$183.75
▲(5.82% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for CSL in the last 3 months. The average price target is AU$183.75 with a high forecast of AU$215.00 and a low forecast of AU$150.00. The average price target represents a 5.82% change from the last price of AU$173.64.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"91":"AU$91","216":"AU$216","122.25":"AU$122.3","153.5":"AU$153.5","184.75":"AU$184.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":215,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$215.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":183.74636363636364,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$183.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$150.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[91,122.25,153.5,184.75,216],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.24,181.0676923076923,183.89538461538461,186.72307692307692,189.55076923076925,192.37846153846155,195.20615384615385,198.03384615384616,200.86153846153846,203.68923076923076,206.5169230769231,209.3446153846154,212.1723076923077,{"y":215,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.24,178.66356643356644,179.08713286713288,179.51069930069932,179.93426573426575,180.35783216783219,180.78139860139862,181.20496503496503,181.62853146853146,182.0520979020979,182.47566433566433,182.89923076923077,183.3227972027972,{"y":183.74636363636364,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.24,176.0676923076923,173.89538461538461,171.72307692307692,169.55076923076925,167.37846153846155,165.20615384615385,163.03384615384616,160.86153846153846,158.68923076923076,156.5169230769231,154.3446153846154,152.1723076923077,{"y":150,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":193.754,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":173.969,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.979,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":168.268,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.585,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.561,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.347,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.239,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.992,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.852,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.482,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.101,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.24,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetAU$215.00Average Price TargetAU$183.75Lowest Price TargetAU$150.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on AU:CSL
David Bailey
Morgan Stanley
Morgan Stanley
AU$200
Buy
15.18%
Upside
Reiterated
10/23/26
Morgan Stanley Sticks to Its Buy Rating for CSL (CMXHF)
Macquarie Analyst forecast on AU:CSL
Unknown Analyst
Macquarie
Not Ranked
Macquarie
AU$174
Hold
0.21%
Upside
Reiterated
10/22/26
Macquarie Reaffirms Their Hold Rating on CSL (CMXHF)
Citi Analyst forecast on AU:CSL
Laura Sutcliffe
Citi
Citi
AU$180
Hold
3.66%
Upside
Reiterated
10/22/26
Analysts Conflicted on These Healthcare Names: Newron Pharmaceuticals SpA (Other OTC: NWPHF) and CSL (Other OTC: CMXHF)
Jefferies Analyst forecast on AU:CSL
David Stanton
Jefferies
Jefferies
AU$146.5→AU$161.5
Hold
-6.99%
Downside
Reiterated
10/06/26
Analysts Conflicted on These Healthcare Names: vTv Therapeutics (NASDAQ: VTVT) and CSL (Other OTC: CMXHF)
RBC Capital Analyst forecast on AU:CSL
Craig Wong-Pan
RBC Capital
RBC Capital
AU$213→AU$215
Buy
23.82%
Upside
Reiterated
10/06/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Ord Minnett Analyst forecast on AU:CSL
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
AU$180
Buy
3.66%
Upside
Reiterated
10/04/26
CSL (CMXHF) Gets a Buy from Ord Minnett
Canaccord Genuity Analyst forecast on AU:CSL
Shane Storey
Canaccord Genuity
Canaccord Genuity
AU$185
Hold
6.54%
Upside
Reiterated
10/01/26
Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF) and Newron Pharmaceuticals SpA (Other OTC: NWPHF)
UBS Analyst forecast on AU:CSL
David Low
UBS
UBS
AU$181
Buy
4.24%
Upside
Reiterated
09/02/26
UBS Sticks to Its Buy Rating for CSL (CMXHF)
Morgans Analyst forecast on AU:CSL
Derek Jellinek
Morgans
Morgans
AU$187.71
Buy
8.10%
Upside
Reiterated
09/01/26
Analysts' Top Healthcare Picks: Oneview Healthcare Chess Depository Interests repr 1 (ONVVF), CSL (CMXHF)
Jarden Analyst forecast on AU:CSL
Steven Wheen
Jarden
Jarden
AU$207
Buy
19.21%
Upside
Upgraded
08/19/26
Positive Report for CSL (CMXHF) from Jarden
Bell Potter Analyst forecast on AU:CSL
Thomas Wakim
Bell Potter
Bell Potter
AU$120→AU$150
Hold
-13.61%
Downside
Reiterated
08/19/26
Bell Potter Keeps Their Hold Rating on CSL (CMXHF)
Goldman Sachs Analyst forecast on AU:CSL
Davinthra Thillainathan
Goldman Sachs
Goldman Sachs
AU$311→AU$212.1
Buy
22.15%
Upside
Reiterated
10/29/25
Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on AU:CSL
David Bailey
Morgan Stanley
Morgan Stanley
AU$200
Buy
15.18%
Upside
Reiterated
10/23/26
Morgan Stanley Sticks to Its Buy Rating for CSL (CMXHF)
Macquarie Analyst forecast on AU:CSL
Unknown Analyst
Macquarie
Not Ranked
Macquarie
AU$174
Hold
0.21%
Upside
Reiterated
10/22/26
Macquarie Reaffirms Their Hold Rating on CSL (CMXHF)
Citi Analyst forecast on AU:CSL
Laura Sutcliffe
Citi
Citi
AU$180
Hold
3.66%
Upside
Reiterated
10/22/26
Analysts Conflicted on These Healthcare Names: Newron Pharmaceuticals SpA (Other OTC: NWPHF) and CSL (Other OTC: CMXHF)
Jefferies Analyst forecast on AU:CSL
David Stanton
Jefferies
Jefferies
AU$146.5→AU$161.5
Hold
-6.99%
Downside
Reiterated
10/06/26
Analysts Conflicted on These Healthcare Names: vTv Therapeutics (NASDAQ: VTVT) and CSL (Other OTC: CMXHF)
RBC Capital Analyst forecast on AU:CSL
Craig Wong-Pan
RBC Capital
RBC Capital
AU$213→AU$215
Buy
23.82%
Upside
Reiterated
10/06/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Ord Minnett Analyst forecast on AU:CSL
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
AU$180
Buy
3.66%
Upside
Reiterated
10/04/26
CSL (CMXHF) Gets a Buy from Ord Minnett
Canaccord Genuity Analyst forecast on AU:CSL
Shane Storey
Canaccord Genuity
Canaccord Genuity
AU$185
Hold
6.54%
Upside
Reiterated
10/01/26
Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF) and Newron Pharmaceuticals SpA (Other OTC: NWPHF)
UBS Analyst forecast on AU:CSL
David Low
UBS
UBS
AU$181
Buy
4.24%
Upside
Reiterated
09/02/26
UBS Sticks to Its Buy Rating for CSL (CMXHF)
Morgans Analyst forecast on AU:CSL
Derek Jellinek
Morgans
Morgans
AU$187.71
Buy
8.10%
Upside
Reiterated
09/01/26
Analysts' Top Healthcare Picks: Oneview Healthcare Chess Depository Interests repr 1 (ONVVF), CSL (CMXHF)
Jarden Analyst forecast on AU:CSL
Steven Wheen
Jarden
Jarden
AU$207
Buy
19.21%
Upside
Upgraded
08/19/26
Positive Report for CSL (CMXHF) from Jarden
Bell Potter Analyst forecast on AU:CSL
Thomas Wakim
Bell Potter
Bell Potter
AU$120→AU$150
Hold
-13.61%
Downside
Reiterated
08/19/26
Bell Potter Keeps Their Hold Rating on CSL (CMXHF)
Goldman Sachs Analyst forecast on AU:CSL
Davinthra Thillainathan
Goldman Sachs
Goldman Sachs
AU$311→AU$212.1
Buy
22.15%
Upside
Reiterated
10/29/25
Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
SIBNSI-Bone
IMUXImmunic
MDWDMediwound
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSL

3 Months
David BaileyMorgan Stanley
Success Rate
13/25 ratings generated profit
52%
Average Return
+3.48%
Copying David Bailey's trades and holding each position for 3 Months would result in 52.00% of your transactions generating a profit, with an average return of +3.48% per trade.
1 Year
David BaileyMorgan Stanley
Success Rate
14/25 ratings generated profit
56%
Average Return
+4.99%
Copying David Bailey's trades and holding each position for 1 Year would result in 56.00% of your transactions generating a profit, with an average return of +4.99% per trade.
2 Years
David BaileyMorgan Stanley
Success Rate
13/25 ratings generated profit
52%
Average Return
+6.60%
Copying David Bailey's trades and holding each position for 2 Years would result in 52.00% of your transactions generating a profit, with an average return of +6.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CSL Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
12
9
2
0
0
Buy
0
4
8
13
14
Hold
19
23
21
20
19
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
36
31
33
33
In the current month, CSL has received 14 Buy Ratings, 19 Hold Ratings, and 0 Sell Ratings. CSL average Analyst price target in the past 3 months is 183.75.
Each month's total comprises the sum of three months' worth of ratings.

CSL Financial Forecast

CSL Earnings Forecast

Next quarter’s earnings estimate for CSL is AU$5.78 with a range of AU$5.23 to AU$6.18. The previous quarter’s EPS was AU$3.26. CSL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.
Next quarter’s earnings estimate for CSL is AU$5.78 with a range of AU$5.23 to AU$6.18. The previous quarter’s EPS was AU$3.26. CSL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.

CSL Sales Forecast

Next quarter’s sales forecast for CSL is AU$12.20B with a range of AU$12.07B to AU$12.31B. The previous quarter’s sales results were AU$10.55B. CSL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.
Next quarter’s sales forecast for CSL is AU$12.20B with a range of AU$12.07B to AU$12.31B. The previous quarter’s sales results were AU$10.55B. CSL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.

CSL Stock Forecast FAQ

What is AU:CSL’s average 12-month price target, according to analysts?
Based on analyst ratings, CSL’s 12-month average price target is 183.75.
    What is AU:CSL’s upside potential, based on the analysts’ average price target?
    CSL has 5.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CSL a Buy, Sell or Hold?
          CSL has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 5 hold ratings and 0 sell ratings.
            What is CSL’s share price target?
            The average share price target for CSL is 183.75. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is AU$215.00 ,and the lowest forecast is AU$150.00. The average share price target represents 5.82% Increase from the current price of AU$173.64.
              What do analysts say about CSL?
              CSL’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of CSL?
                To buy shares of AU:CSL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.